To the safety of Influenza vaccine, the production process is based on the cell lines - Reply

被引:0
|
作者
Fickenscher, Helmut [1 ,2 ]
机构
[1] Univ Kiel, Inst Infekt Med, D-24105 Kiel, Germany
[2] Univ Klinikum Schleswig Holstein, D-24105 Kiel, Germany
关键词
D O I
10.1055/s-0029-1243033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2472 / 2472
页数:1
相关论文
共 50 条
  • [42] Safety and efficacy of influenza vaccine in children
    Goldstein, LGB
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (11) : 1712 - 1715
  • [43] Influenza burden averted with a cell-based quadrivalent seasonal influenza vaccine compared with egg-based quadrivalent seasonal influenza vaccine
    McGovern, Ian
    Taylor, Alexandra
    Sardesai, Aditya
    Toro-Diaz, Hector
    Haag, Mendel
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 371 - 379
  • [44] Single-Cell Approach in Influenza Vaccine Production: Apoptosis and Virus Protein Production
    Schulze-Horsel, Josef
    Schulze, Mareike
    Genzel, Yvonne
    Reichl, Udo
    CELLS AND CULTURE, 2010, 4 : 25 - 28
  • [45] Developments and current challenges in the process of cell culture- based seasonal influenza vaccine manufacture in Japan
    Hamamoto, Itsuki
    GLOBAL HEALTH & MEDICINE, 2024, 6 (02): : 93 - 100
  • [46] Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
    Hansen, John
    Goddard, Kristin
    Timbol, Julius
    Zhang, Lea
    Lewis, Ned
    Dunkle, Lisa
    Izikson, Ruvim
    Klein, Nicola P.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (06):
  • [47] Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell Culture
    Szymczakiewicz-Multanowska, Agnieszka
    Groth, Nicola
    Bugarini, Roberto
    Lattanzi, Maria
    Casula, Daniela
    Hilbert, Anne
    Tsai, Theodore
    Podda, Audino
    JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (06): : 841 - 848
  • [48] Attenuating mutations in the influenza virus genome which may increase the safety of vaccine production
    Whiteley, A
    Trikic, MZ
    Barclay, WS
    OPTIONS FOR THE CONTROL OF INFLUENZA V, 2004, 1263 : 687 - 690
  • [49] Process optimization for high cell density cultivations in cell culture-based viral vaccine production
    Wu, Yixiao
    Liu, Xuping
    Zhao, Liang
    Ye, Qian
    Peng, Wenjuan
    Dai, Weijun
    Hu, Keke
    Tan, Wen-Song
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [50] More on Influenza Vaccine in Young Children REPLY
    Tsai, Theodore F.
    Della Cioppa, Giovanni
    Vesikari, Timo
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26): : 2528 - 2529